Alyssa Caparelli
Medical · Las Vegas, NVNPI 1467198879
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $4,546 of the $5,054 with a category attached, or 89.9%. 24 manufacturers reported payments, led by AbbVie at 24.3% of the total.
Across 234 payments — averaging $21.60 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$1K
- UCB, Inc.$1K
- Johnson & Johnson$734
- Dermavant Sciences, Inc.$383
- Sanofi$316
- Pfizer$239
- plus $1K from 18 others
What the payments were for
- Food & beverage$4,54690%
- Education$50810%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 61 | $1,226 |
| UCB, Inc. | 25 | $1,033 |
| Johnson & Johnson | 27 | $734 |
| Dermavant Sciences, Inc. | 41 | $383 |
| Sanofi | 15 | $316 |
| Pfizer | 10 | $239 |
| Sun Pharmaceutical Industries Inc. | 11 | $203 |
| LEO Pharma Inc. | 9 | $164 |
| Lilly USA, LLC | 6 | $111 |
| Sanofi-aventis U.S. LLC | 1 | $99 |
| Arcutis Biotherapeutics, Inc. | 5 | $95 |
| Biofrontera Inc. | 5 | $88 |
| Regeneron Healthcare Solutions, Inc. | 3 | $83 |
| Organon | 4 | $56 |
| Smith+Nephew | 2 | $29 |
| Merz North America, Inc. | 1 | $28 |
| Almirall LLC | 1 | $25 |
| Amgen | 1 | $25 |
| Novartis | 1 | $23 |
| Sanofi Pasteur Inc. | 1 | $21 |
| Botanix SB Inc | 1 | $21 |
| Boehringer Ingelheim | 1 | $21 |
| Galderma Laboratories, L.p. | 1 | $20 |
| Verrica Pharmaceuticals Inc. | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Bimzelx$550
How this compares
$5,054 in reported general payments places this provider in the 80th percentile of 250 medical providers in Nevada.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Clobetasol Propionate | 59 | $2,805 |
| Metronidazole | 25 | $2,639 |
| Triamcinolone Acetonide | 160 | $1,796 |
| Ketoconazole | 59 | $988 |
| Betamethasone Dipropionate | 24 | $985 |
| Tretinoin | 12 | $853 |
| Doxycycline Hyclate | 61 | $831 |
| Betamethasone Diprop AugmentedBetamethasone/Propylene Glyc | 28 | $817 |
| Clindamycin Phosphate | 30 | $739 |
| Mupirocin | 98 | $734 |
| Econazole Nitrate | 18 | $501 |
| ValacyclovirValacyclovir Hcl | 25 | $307 |
| Doxycycline Monohydrate | 20 | $266 |
| Hydrocortisone | 29 | $235 |
| Methylprednisolone | 26 | $129 |
Paid to pharmacies, not to this prescriber.
Other medical in Las Vegas
- John NotabartoloLas Vegas$284K
- Rachel BowersLas Vegas$29K
- Spencer MeierLas Vegas$24K
- Megan WieselLas Vegas$19K
- Tai PhamLas Vegas$16K
- Eric HilmesLas Vegas$15K
- Wardon OjedapoLas Vegas$12K
- Melchor GochiocoLas Vegas$11K
- Keesha KaplanLas Vegas$11K
- Adelbert WadsworthLas Vegas$11K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.